Verrica Pharmaceuticals Inc.

VRCA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001660334

SEC filings (opens in a new tab)

In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Verrica Pharmaceuticals Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of VRCA: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	51	1	57	+7
Shares	8.88M	2.13K	11.3M	+2.45M (+27.6%)
Value	$72.1M	$17.0K	$21.8M	−$50.3M (−69.8%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Verrica Pharmaceuticals Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to VRCA in Q2 2022
Institution	Shares	Value	% of portfolio
Point72 Asset Management, L.P.	753,945	$1.45M	0.01%
CVI Holdings, LLC	450,000	$864.0K	0.06%
Miracle Mile Advisors, LLC	125,000	$240.0K	0.01%
Ergoteles LLC	64,300	$123.0K	0.00%
Two Sigma Investments, LP	54,267	$104.0K	0.00%
Renaissance Technologies LLC	47,900	$92.0K	0.00%
Occudo Quantitative Strategies LP	38,687	$74.0K	0.01%
Schonfeld Strategic Advisors LLC	32,600	$62.0K	0.00%
XTX Topco Ltd	25,795	$50.0K	0.02%
Virtu Financial LLC	24,690	$47.0K	0.00%
Squarepoint Ops LLC	18,808	$36.0K	0.00%
Boothbay Fund Management, LLC	16,667	$32.0K	0.00%
Susquehanna International Group, LLP	14,606	$28.0K	0.00%
Qube Research & Technologies Ltd	11,353	$22.0K	0.00%
Ground Swell Capital, LLC	10,205	$20.0K	0.04%
Jane Street Group, LLC	10,579	$20.0K	0.00%
HRT Financial LP	10,146	$19.0K	0.00%
Federated Hermes, Inc.	931	$2.00K	0.00%
Cubist Systematic Strategies, LLC	1,200	$2.00K	0.00%
Benjamin F. Edwards & Company, Inc.	500	$1.00K	0.00%
Simplex Trading, LLC	942	$1.00K	0.00%
Credit Suisse AG	7	$0	0.00%
CoreCap Advisors, LLC	200	$0	0.00%

Sold out (16)

Institutions that held Verrica Pharmaceuticals Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of VRCA in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Altium Capital Management LP	97,887	$794.0K
Nuveen Asset Management, LLC	32,788	$277.0K
Charles Schwab Investment Management Inc	33,450	$272.0K
Alliancebernstein L.P.	19,100	$155.0K
Rhumbline Advisers	12,769	$104.0K
Deutsche Bank AG	7,323	$60.0K
American International Group, Inc.	6,502	$53.0K
California State Teachers Retirement System	5,520	$45.0K
Allspring Global Investments Holdings, LLC	5,111	$41.0K
Barclays PLC	2,125	$17.0K
Amalgamated Bank	2,133	$17.0K
Ameritas Investment Partners, Inc.	1,080	$9.00K
EverSource Wealth Advisors, LLC	427	$3.00K
STRS Ohio	300	$2.00K
CWM, LLC	55	$0
Ellevest, Inc.	14	$0

Not filed for Q2 2022 yet (1)

Institutions that held Verrica Pharmaceuticals Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VRCA in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Amalgamated Financial Corp.	2,133	$17.0K